Bacteriophages a viable alternative to antibiotic use in poultry farming
Sep. 26, 2020•0 likes
0 likes
Be the first to like this
Show More
•122 views
views
Total views
0
On Slideshare
0
From embeds
0
Number of embeds
0
Download to read offline
Report
Science
Poster prepared by Nicholas Svitek, ILRI Angela Makumi, Nicoline de Haan and Sylvain Moineau for the Virtual Livestock CRP Planning Meeting, 8-17 June 2020
Bacteriophages a viable alternative to antibiotic use in poultry farming
NUTRITION & FOOD
SECURITY
§ Demand for poultry products predicted to grow by
800% by 2050 in Africa.
§ Antimicrobial resistance (AMR) is an increasing
problem in poultry farming.
§ Among strategies to control bacterial infections, the
use of bacterial viruses (bacteriophages or phages) is
going through a renaissance, particularly as
alternatives or complements to antibiotics.
Bacteriophages a viable
alternative to antibiotic use
in poultry farming
Context
• The poultry industry: Increased globally by 5% every
year for the past three decades; shows a higher
growth rate than the pig (3%) and beef (1.5%)
sectors.
• The problem: Pullorum disease and fowl typhoid are
among the most important bacterial diseases
affecting chicken health and productivity. Salmonella
is also transmitted to humans mostly by poultry
products.
• The problem of AMR: About 75% of antibiotics
administered to poultry are released in the
environment, at least 30% of Salmonella from poultry
farms are multidrug resistant.
• What changes do you want to achieve?: Reduce the
use of antibiotics in poultry farming and reduce the
problem of antimicrobial resistance.
• Other information related to the project: The
project is taking place in Kenya for the benefit of
women chicken farmers.
Our innovative approach
• Using bacteriophages (viruses that infect and kill
bacteria): They are ecologically safe, do not cause
side effects, are ubiquitous, are more specific than
antibiotics, and have the advantage of co-evolving
with their bacterial host, reducing the emergence of
long-term resistance.
Future steps
• Post-2021 potential: Field trial of best candidates.
• What are other potential applications of this
particular project: Application to other farming or
agricultural systems.
• Scaling objectives?: In partnership with a Canadian
company to scale up phage production. Hopefully, this
approach can be extended to other African countries.
Partners
Outcomes
• A collection of Kenyan Salmonella-specific phages
have been isolated and will be tested soon in vivo:
Nicholas Svitek, ILRI
n.svitek@cgiar.org The CGIAR Research Program on Livestock thanks all donors & organizations
which globally support its work through their contributions to the CGIAR Trust
Fund. cgiar.org/funders
This document is licensed for use under the Creative Commons
Attribution 4.0 International Licence. June 2020
LIVESTOCK HEALTH
S
.B
ra
e
n
d
e
ru
p
S
.
T
y
p
h
im
u
riu
m
(S
T
M
)
S
.
B
ra
e
n
d
e
b
u
rg
S
.
E
n
te
ritid
is
S
.
P
u
llo
ru
m
S
.C
h
o
le
ra
s
iu
s
S
.
T
y
p
h
im
u
riu
m
0
1 0
2 0
3 0
4 0
5 0
Percentage(%)
K ia m b u
N a iro b i
% of crude extracts
per total number
sampled in each
county
Crude Kenyan phage extracts
[zone of bacterial lysis]
With Angela Makumi, Nicoline
de Haan, Sylvain Moineau
Electron microscopy of
phages (green) binding
to bacteria (blue)